Pitobrutinib/Pirtobrutinib (pirtobrutinib) price per box and patient purchase cost reference

Pitubrutinib is a new Bruton's tyrosine kinase (BTK) inhibitor, mainly used to treat certain types of B cell lymphoma and chronic lymphocytic leukemia. In the domestic market, the original drug Pitobrutinib is already on the market, but it has also been included in medical insurance. The common specifications are 100mg 14 tablets 4 tablets. Each box may be sold for more than 40,000 yuan. The burden on patients is high, and medication budget and economic planning need to be made in advance.

For overseas markets, the original drug of pitubrutinib is available in European and American versions. Common specifications include50mg30tablets and100mg60tablets are priced at nearly 100,000 yuan per box, which is very expensive. This requires most patients to consider exchange rate changes and transportation costs when purchasing overseas. At the same time, they should ensure drug quality and safety through formal channels and avoid purchasing drugs from informal sources.

In order to reduce financial pressure, some patients will choose overseas generic versions. Generic drugs of pitobrutinib are already on the market overseas, and their drug ingredients are basically the same as the original drug. For example, the price of 50 mg 30 mg tablets produced by a Lao pharmaceutical factory may be more than 2,000 yuan per box (the price may fluctuate due to the exchange rate). The price is much lower than that of the original drug, providing patients with a more economical choice. However, when using generic drugs, you also need to pay attention to the legality, production qualifications and safety of the drugs.

When purchasing and using pitubrutinib, patients should follow the doctor's prescription and guidance, choose regular pharmacies or officially authorized channels to purchase, and avoid obtaining the drug through informal networks or personal channels. Patients should pay attention to the efficacy and possible adverse reactions during medication, regularly review blood images and liver and kidney functions, and reasonably arrange treatment plans and financial expenditures to ensure medication safety and treatment continuity.

Reference materials:https://go.drugbank.com/drugs/DB17472

xa0